Featured Press

Joi + Blokes, the precision health platform focused on hormone optimization and personalized care, has announced a strategic combination with Gina Bartasi and her company YourJOY.ai to add fertility to its existing hormonal health platform. Bartasi will join as founding partner and CEO of the fertility division.

When Josh Whalen‘s once athletic, rugby-playing physique morphed into a heftier “dad bod,” he figured it was just the reality of getting older.

That’s how he dismissed other symptoms, too. His sex drive plummeted and he felt super tired — but working as a entrepreneur in his mid-30s, he attributed his problems to the mounting pressures of work and parenting two kids. And he wasn’t motivated to do anything about it.

Flowspace highlights how hormonal shifts can significantly impact cardiovascular risk in midlife and beyond, especially as estrogen levels decline and traditional lipid profiles become less protective. The piece underscores the importance of proactive screening and personalized care in this transitional life stage.

Dr. Melissa Loseke emphasizing why midlife bloodwork, beyond standard panels, matters for women navigating perimenopause and menopause.

The ultimate problem-solver, Katy Whalen joined forces with her husband’s online platform, Joi + Blokes, giving women nationwide hormonal and wellness support.

In 2025, the women’s health market advanced on multiple fronts, fueled by increased recognition of research gaps, strong funding pledges, and regulatory shifts. A record $2.5 billion commitment from the Bill & Melinda Gates Foundation over five years aimed at transforming women’s health R&D — particularly in underfunded areas like menstrual, gynecological, sexual, and maternal health — was among the year’s most significant funding news.

Joi + Blokes, a national precision medicine and telehealth platform, announced the publication of a peer-reviewed clinical study in collaboration with Brigham Young University (BYU) that evaluates the outcomes of its proprietary, biomarker-guided precision medicine protocols. The study was published in the scientific journal Life and assesses changes in key inflammatory biomarkers among adults aged 40 to 69.

“This study evaluates a precision medicine framework applied in real clinical practice,” said Paul R. Reynolds, PhD, Professor of Cell Biology and Physiology at Brigham Young University and lead author.